Plain-English translation of NCT06309511 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hypertension research guide →This study is looking at a specific measurement called the Subendocardial Viability Ratio (SEVR), which shows how well blood is reaching the heart muscle in people with high blood pressure. Researchers will use a painless ultrasound technique called arterial tonometry to take this measurement. The goal is to understand which factors affect this measurement and whether it can predict serious heart problems in the future.
People with high blood pressure are at risk for heart disease, but doctors don't always have good tools to predict who will have the most problems. This study hopes to show whether this simple, non-invasive measurement can help doctors identify patients at highest risk and potentially prevent heart attacks and strokes.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will visit your high blood pressure clinic and receive a painless ultrasound scan of your neck and heart area. The test uses gentle pressure on your skin to measure blood pressure waves and blood flow to your heart. Your basic health information and medical history will be recorded in a database so researchers can look for patterns between the measurement and heart health outcomes.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Italy
Sponsor
Istituto Auxologico Italiano
Enrollment target
~3,000 participants
Started
October 2022
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Paolo Salvi, MD
Istituto Auxologico Italiano
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.